Baloxavir Marboxil

3 trials 1 recruiting JAnti-infectives

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

1 Recruiting

2 Completed trials

3 Sponsors

16 Countries

Phase III

Phase III: 3

Oversight events:

1 serious breach 1 unexpected event across 1 trial

View oversight register →

Indications tested

Influenza 1 Pneumonia 1

Sponsors using this IMP

F. Hoffmann-La Roche AG 1 Universitair Medisch Centrum Utrecht 1 University Of Oxford 1

All trials

3 total

RECOVERY Recruiting

2023-507441-29-00 Phase III 9 countries University Of Oxford
A Study of Susceptibility to Baloxavir Marboxil in Patients with Influenza and its transmission to their household contacts Ended

2023-504672-22-00 Phase III 3 countries F. Hoffmann-La Roche AG
Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia (REMAP-CAP) Ended

2023-507889-89-00 Phase III 13 countries Universitair Medisch Centrum Utrecht

Showing 1–3 of 3 trials

← All drugs A–Z